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Background: DNA capture technologies combined with high-throughput sequencing now enable cost-effective,
deep-coverage, targeted sequencing of complete exomes. This is well suited for SNP discovery and genotyping.
However there has been little attention devoted to Copy Number Variation (CNV) detection from exome capture
datasets despite the potentially high impact of CNVs in exonic regions on protein function.
Results: As members of the 1000 Genomes Project analysis effort, we investigated 697 samples in which 931 genes
were targeted and sampled with 454 or Illumina paired-end sequencing. We developed a rigorous Bayesian
method to detect CNVs in the genes, based on read depth within target regions. Despite substantial variability in
read coverage across samples and targeted exons, we were able to identify 107 heterozygous deletions in the
dataset. The experimentally determined false discovery rate (FDR) of the cleanest dataset from the Wellcome Trust
Sanger Institute is 12.5%. We were able to substantially improve the FDR in a subset of gene deletion candidates
that were adjacent to another gene deletion call (17 calls). The estimated sensitivity of our call-set was 45%.
Conclusions: This study demonstrates that exonic sequencing datasets, collected both in population based and
medical sequencing projects, will be a useful substrate for detecting genic CNV events, particularly deletions. Based
on the number of events we found and the sensitivity of the methods in the present dataset, we estimate on
average 16 genic heterozygous deletions per individual genome. Our power analysis informs ongoing and future
projects about sequencing depth and uniformity of read coverage required for efficient detection.Background
Copy Number Variations (CNVs) i.e. deletions and
amplifications, are an essential part of normal human
variability [1]. Specific CNV events have also been linked
to various human diseases [2], including cancer [3,4]
autism [5,6] and schizophrenia [7]. Historically, large
CNV events can be observed using FISH [8] but system-
atic, genome-wide discovery of CNVs started with
microarray-based methods [9-11] which can detect
events down to 1 kb resolution. As with all hybridization
based approaches, these methods are blind in repetitive
and low complexity regions of the genome where probes
cannot be designed. High throughput sequencing with
next-generation technologies have enabled CNV detec-
tion at higher resolution (i.e. down to smaller event size),* Correspondence: marth@bc.edu
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reproduction in any medium, provided the orin whole-genome shotgun datasets [12-14]. However,
despite decreasing costs, deep-coverage (≥ 25×) whole-
genome data is still prohibitively expensive for routine
sequencing of hundreds of samples, and in low-coverage
(2-6× base coverage) datasets detection sensitivity and
resolution is limited to long genomic events [1].
Targeted DNA capture technologies combined with
high-throughput sequencing now provide a reasonable
balance between coverage and sequencing cost in a sub-
stantial portion of the genome, and full-exome sequen-
cing projects are presently collecting ≥ 25× average
sequence coverage in thousands of samples. CNV events
in exonic regions are important because the deletions of
one or both copies, or amplifications affecting exons, are
likely to incur phenotypic consequences.
Current algorithms for detecting CNVs in whole-genome
shotgun sequencing data use one of four signals as evidence
for an event: (1) aberrantly mapped mate-pair reads (RP or
read pair methods); (2) split-read mapping positions (SR);. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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crease of mapped read depth (RD methods). Unfortunately,
these methods are not generally applicable for CNV detec-
tion in capture sequence data without substantial modifica-
tions. SR, RP, and AS based methods are sensitive only to
CNVs in which mapped reads or fragments span the event
breakpoint (s). In the case of exon capturing data, this
restricts detection to CNV events where at least one break-
point falls in a targeted exon. RD based methods suffer
from large fluctuations of sequence coverage stemming
from variability in probe-specific hybridization affinities
across different capture targets (in this case: exons) and sets
of such targets (in our case: genes), and from the over-
dispersion of the read coverage distribution in the same tar-
get across different samples. Presumably because of the
technical challenges, and despite the importance of deletion
or amplification events within exons, there are currently no
reported CNV detection algorithms for targeted DNA cap-
ture based exon-sequencing data (with the exception of
methods for tumor-normal datasets [15] where the read
depth measured in the normal sample can be used for
normalization – signal not available in the case of popula-
tion sequencing).
In this study, we set out to develop a CNV detection al-























Figure 1 Workflow of the CNV detection method. A. Median Read Dep
coverage (NA18523 shown). B. The gene affinity is estimated for each gene
for that gene (TRIM33 shown). C. Example of observed (magenta) and expe
observed read depths were roughly half of the expected values for genesbased on RD measurement, and detects samples with non-
normal copy number in the capture target regions. As par-
ticipants of the 1000 Genomes Project, we took part in the
data analysis of the “Exon Sequencing Pilot” dataset [16],
where 12,475 exons from over 900 genes were targeted




Our algorithm is an extended version of RD-based CNV
detection that aims to mitigate the vast target-to-target
(and consequently gene-to-gene) heterogeneity of read
coverage by normalization procedures roughly correspond-
ing to those employed in CNV detection methods from
microarray hybridization intensity data. The overall work-
flow of our method is shown in Figure 1 and described in
greater detail in the Methods section. For a given gene in a
given sample (we will use the abbreviation GSS: Gene-
Sample Site throughout the paper), we define the read
depth as the number of uniquely mapped reads whose 5’
end falls within any of the targeted exons within that gene.
We compare this measurement with an expected read
depth (Eq. 2, Methods), based on a “gene affinity” calcu-
lated from measured read depth for that gene across all 























th (MRD) is calculated for each sample, as a measure of sample
as the slope of the least-square-error linear fit between MRD and RD
cted (green) read depth for three samples and four genes. The
TRIM33 and NRAS, in sample NA18523, and detected as deletions.
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ance due to target-specific hybridization), and the overall
read depth for the sample (to account for the variance
of read coverage due to the overall sequence quantity
collected for the sample under examination). We then
use a Bayesian scheme to determine whether the mea-
sured coverage is consistent with normal copy number
(e.g. CN = 2 for autosomes), or aberrant copy number
(i.e. homozygous deletion: CN = 0, heterozygous deletion:
CN = 1, or amplification: CN > 2). We have included two
algorithmic variants: One is suitable for CNV events that
occur at a low allele frequency (i.e. in a small fraction of
the samples), and the other for capturing higher-frequency
deletion events (see Methods).
Dataset
In this study we analyzed the exon capture sequencing
dataset collected by the 1000 Genomes Project Exon Se-
quencing Pilot, including 931 genes processed with Agi-
lent liquid-phase and Nimblegen solid-phase capture
methods, and sequenced from 697 individuals with
Illumina paired-end and/or 454 technologies. The sam-
ples in the dataset have been sequenced by four different
data collection centers (Washington University, WU;
Wellcome Trust Sanger Institute, SC; Broad Institute, BI;
and Baylor College of Medicine, BCM) using different
pairings of capture and sequencing technologies (Table 1
and Table 2). As our method relies on an estimate of the
gene-specific hybridization affinity, it requires that such
affinities are consistent across all samples analyzedTable 1 Properties of datasets from different sequencing cen
Total sample count




Base coverage(mean ± standard deviation)
Read depth per gene(mean ± standard deviation)
MRD(mean ± standard deviation)
Number of exons
Exons overlapped with segmental duplication regions
Number of genes (passing QC)
Genes overlapped with segmental duplication regions
Over-dispersion factor(mean ± standard deviation)
Quality index(mean ± standard deviation)
Expected detection sensitivity based on quality index
Number of callsh = 0.65 either with or without a neighboring call
Number of callsh = 0.1 either with a neighboring callsimultaneously. According to Principal Component
Analysis of the observed read depths, (Figure 2A, see
Methods), target and genes affinities are inconsistent
across data from different centers, and therefore we
analyzed each dataset separately. We only considered
datasets with at least 100 samples (SC, BI, BCM) so we
can obtain sufficient sample statistics across genes.
After filtering out genes and samples that didn’t meet
our minimum read depth requirements (see Methods),
we were left with the following datasets: SC (862 genes
in 106 individuals sequenced with Illumina), BI (739
genes in 110 samples sequenced with Illumina), and
BCM (439 genes in 349 samples sequenced with 454)
(Table 1). The number of genes that passed our filters
was substantially lower in the BCM dataset both due to
lower overall 454 coverage (see below), and because the
longer 454 reads result in lower RD (fewer reads) when
compared to shorter Illumina reads, even at equivalent
base coverage.
Sample coverage and gene affinities
As a metric of coverage for each sample, we calculated
the sample-specific median gene RD, referred to as “Me-
dian Read Depth” (MRD); see Figure 1A and Methods.
MRD was highest for the SC samples (1,710 ± 1,073, me-
dian 1,491 reads/gene; data presented as mean±standard
deviation), see Figure 2B. MRD was somewhat lower for
the BI samples (1,070 ± 803, median 860 reads/gene), and
much lower in the BCM dataset (97 ± 52, median 87
reads/gene). As mentioned above, RD (distributed as inters
SC BCM BI WU
117 352 161 93
106 349 110 82
Illumina 454 Illumina Illumina
0.21 0.30 0.50 0.72
50 33 45 51
56 ± 34 23 ± 12 70 ± 61 29 ± 9
2309 ± 3166 106 ± 171 1329 ± 2053 977 ± 1382
1710 ± 1073 97 ± 52 1070 ± 803 599 ± 164
8174 8174 8174 8174
458 (5.6%) 458 (5.6%) 458 (5.6%) 458 (5.6%)
862 439 739 1
29 (3.3%) 11(2.5%) 23(3.1%) 0(0.0%)
7.9 ± 8.2 2.1 ± 1.1 6.4 ± 5.5 N/A
9.4 ± 8.8 5.5 ± 2.3 7.6 ± 5.6 N/A
0.46 0.20 0.41 N/A
36 4 56 N/A
17 0 11 N/A
Table 2 Data characteristized by sequencing center and
population
SC
CEU CHB JPT TSI YRI
Number of samples 18 14 9 51 14
Male/Female 9/9 5/9 5/4 24/27 2/12
Average read depth
per gene
1679 1701 1597 1617 1865
Read length 36 36 36 36 36
BCM
CEU CHB CHD JPT LWK YRI
Number of samples 40 62 78 16 108 45
Male/Female 20/20 15/47 38/40 5/11 51/57 22/23
Average read depth
per gene
178 131 171 243 128 165
Read length 258 323 339 300 336 322
BI
CEU CHB CHD JPT YRI
Number of samples 16 13 28 34 19
Male/Female 9/7 11/2 12/16 16/18 12/7
Average read depth
per gene
1623 1631 1675 1104 1612
Read length 73 75 74 75 76
Population abbreviations:
CEU – Utah residents with Northern and Western European ancestry.
CHB – Han Chinese in Beijing.
CHD – Chinese in Denver, Colorado.
JPT – Japanese in Tokyo, Japan.
LWK – Luhya in Webuye, Kenya.
TSI – Toscans in Italy.
YRI – Yoruba in Ibadan, Nigeria.
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coverage was highest in the BI data (70 ± 61, median 56
reads/base), followed by SC (56 ± 34, median 50 reads/
base). The much lower RD in the 454 reads from BCM
corresponds to only somewhat lower base coverage
(23 ± 12, median 21 reads/base).
For each target we define a quantity, the “target affinity”,
intended to describe the number of reads (RD) being
mapped to a given target, relative to the sample-specific
MRD over all capture targets. Analogously, we define the
gene-specific affinity as the ratio of the number of reads
(RD) mapped to the targets (exons) belonging to that gene
and the gene-specific MRD for that same sample (see
Methods, Figure 2D). In general, tighter distributions of af-
finities, with mean and median as close to 1 as possible,
are desirable because these correspond to more even target
coverage. The observed gene affinities for our datasets
(Figure 2D) were as follows: SC (1.40 ± 1.43, median 1.04),
BI (1.58 ± 1.59, median 1.20), and BCM (2.63 ± 3.03, me-
dian 1.73). Because of the more favorable gene affinities,
we used the SC data as our primary dataset for method de-
velopment and experimental validations.CNV candidates detected in the data
According to our Bayesian detection scheme, we call a het-
erozygous deletion event in a gene if the posterior prob-
ability value of CN = 1, i.e. P(CN=1 | RD) ≥ h where h is a
pre-defined probability cutoff value. Similarly, a homozy-
gous deletion is where P(CN=0 | RD) ≥ h. Although we
detected both deletions and amplifications in the analyzed
datasets, deletion events (even when in a heterozygous
state) provide easier detectable signal than amplifications.
For this reason we only discuss deletion events here and
report candidate amplifications in Table 3.
Using a cutoff value h = 0.65, we detected deletion 96
events in the three datasets (36 in SC, 56 in BI, and 4 in
BCM), all heterozygous deletions (Table 4, Table 5 and
Table 6). The top ranked deletions are shown in Figure 3A.
Most of the events were found in the Tuscan population,
which constituted about half of the sample set. 10 of 36
gene deletions in the SC dataset were found in two sam-
ples (NA18523 and NA20533), clustered in a contiguous
string of deleted genes extending approximately 3 Mb on
chromosome 1 and 17, respectively, a genomic deletion
event that we were also able to find in the 1000 Genomes
Project whole-genome Low Coverage Pilot data [16] from
the same samples (data not shown).
When two or more gene deletions are detected in
close proximity, it is likely that these events are part of a
single, longer genomic deletion spanning the genes.
With this in mind, we searched the sequenced genes for
deletion events at a lower probability cutoff value
(h = 0.1), but required that an immediate neighbor of a
candidate gene be located within 3 Mbp and also show
evidence for a deletion at the same probability cutoff.
This procedure produced 17 heterozygous deletion calls
in the SC dataset, 11 calls in the BI dataset (but no such
calls were made in the BCM dataset). The union of both
callsets (i.e. those made with and without use of neigh-
boring information) resulted in a total of 107 unique de-
letion events (41 in SC dataset, 62 in BI, and 4 in BCM).
We note that none of the events we detected in our
data were at high allele frequency. In fact, even the most
“common” events were only present in two samples, as
heterozygotes.
Call-set accuracy assessment
To assess the accuracy of deletion calls made in the SC
dataset, we performed experimental validations on calls
made with posterior probability ≥ 0.65 without neighbor
information, using qPCR (see Methods). The validation
results are summarized in Figure 3B. Of the 36 calls
made, we evaluated 26. All 22 calls with posterior prob-
ability ≥ 0.95 and 4 out of 12 calls (randomly selected)
with posterior probability between 0.65 and 0.95 were
submitted for validation. 6 were considered positively























































Observed read depth 
Figure 2 Data characteristics for the 1000 genomes exon sequencing pilot datasets. A. Principal component analysis of a “mixed” read
depth matrix built with data from 3 different sequencing centers, SC (Wellcome Trust Sanger Institute), BI (Broad Institute) and BCM (Baylor
College of Medicine). Each sample is represented as a point in the plot, with the first principal component plotted vs. the second principal
component. Samples from different sequencing centers cluster separately from each other within this space, suggesting significant differences in
the gene affinities among these three datasets. B. Distributions of MRD for each of the BCM, BI and SC samples C. Histogram of RD across all
GSSs in the three datasets. D. Histogram of gene affinities across genes within each of the three datasets. E. Distributions of the RD
over-dispersion factor (ODF) in our data.
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validations produced positive results for 12 calls (mea-
sured fold change < 0.7) and negative results for 3 calls
(measured fold change > 0.8). The validation results for
the remaining 5 were inconclusive. All the 17 neigh-
bored calls with posterior probability ≥ 0.1 were selected
for validation. 7 were considered valid per previous pub-
lication [17], 7 were positively validated de novo and
none was found invalid; validation was not obtained for
the remaining 3. The union of those two callsetscounted 41 calls and 32 of them were evaluated. Among
these 32 calls 7 were considered positively validated per
previous publication [17], 14 were positively validated de
novo, 3 were invalidated, 5 were inconclusive and 3 did
not obtain the validation results. The numbers of vali-
dated calls are presented in Table 7. The selection pro-
cedure for site validation was as follows: (1) We selected
sites for validation (in some categories, all candidates, in
others, a random selection); (2) we searched the litera-
ture, and removed from the validation list events that we
Table 3 Gene duplication calls in the SC dataset
Population Sample Gene name Gene function Chr Start [bp] End [bp] Posterior
probablity
RDobserved RDexpected
CEU NA12348 CD300LB CD300 molecule-like family member b 17 70030472 70039195 1.000 638 420
TSI NA20533 CLDN10 claudin 10 13 95003009 95028269 1.000 2108 1582
CHB NA18526 SNRNP27 small nuclear ribonucleoprotein 27 kDa
(U4/U6.U5)
2 69974621 69977184 1.000 530 383
CHB NA18532 CES1 carboxylesterase 1 (monocyte/macrophage
serine esterase 1)
16 54401930 54424468 1.000 501 337
TSI NA20752 NOM1 nucleolar protein with MIF4G domain 1 7 156435193 156455158 1.000 1335 966
TSI NA20796 AHNAK AHNAK nucleoprotein 11 62040792 62059238 1.000 7330 5169
TSI NA20796 ZNF264 zinc finger protein 264 19 62408577 62416161 0.999 1276 888
TSI NA20801 GPR128 G protein-coupled receptor 128 3 101811391 101896535 0.998 14747 8265
TSI NA20772 STX16 syntaxin 16 20 56660469 56684753 0.998 2101 1605
TSI NA20769 MRPS6 mitochondrial ribosomal protein S6 21 34419511 34436770 0.998 1585 1203
TSI NA20774 ELAVL4 ELAV (embryonic lethal, abnormal vision,
Drosophila)-like 4 (Hu antigen D)
1 50383216 50439437 0.998 782 567
TSI NA20804 CYP2A13 cytochrome P450, family 2, subfamily A,
polypeptide 13
19 46291375 46293686 0.997 1289 984
TSI NA20774 CREB5 cAMP responsive element binding protein 5 7 28494318 28825421 0.996 1435 954
TSI NA20796 ZNF32 zinc finger protein 32 10 43459504 43461587 0.996 911 646
TSI NA20520 C6orf145 chromosome 6 open reading frame 145 6 3668852 3683381 0.995 2015 1601
CEU NA12348 GDNF glial cell derived neurotrophic factor 5 37851510 37870647 0.994 306 217
CHB NA18561 PSMB4 proteasome (prosome, macropain) subunit,
beta type, 4
1 149638688 149640730 0.986 3461 2216
CEU NA12546 DAZAP2 DAZ associated protein 2 12 49920394 49922509 0.985 2265 1651
TSI NA20752 AATF apoptosis antagonizing transcription factor 17 32380539 32488077 0.976 1157 843
CEU NA12749 PAQR5 progestin and adipoQ receptor family
member V
15 67439474 67483215 0.976 1684 1239
TSI NA20769 BCL2L11 BCL2-like 11 (apoptosis facilitator) 2 111597794 111638279 0.965 1813 1435
TSI NA20804 PILRA paired immunoglobin-like type 2 receptor alpha 7 99809603 99835466 0.909 962 752
TSI NA20589 C8orf85 chromosome 8 open reading frame 85 8 118019664 118024121 0.903 147 91
TSI NA20752 CCKAR cholecystokinin A receptor 4 26092358 26100987 0.902 712 532
JPT NA18973 HBG2 hemoglobin, gamma G 11 5278820 5523329 0.901 4151 3094
TSI NA20774 HIPK1 homeodomain 1 114298778 114317657 0.900 2374 1626
TSI NA20774 ODC1 ornithine decarboxylase 1 2 10498301 10502609 0.897 1489 935
TSI NA20796 STBD1 starch binding domain 1 4 77446947 77450177 0.885 978 664
TSI NA20589 CRIPAK cysteine-rich PAK1 inhibitor 4 1378300 1379640 0.877 76 38
YRI NA19189 PSMB4 proteasome (prosome, macropain) subunit,
beta type, 4
1 149638688 149640730 0.853 2622 2090
TSI NA20774 STX16 syntaxin 16 20 56660469 56684753 0.811 949 704
JPT NA18980 CES1 carboxylesterase 1 (monocyte/macrophage
serine esterase 1)
16 54401930 54424468 0.788 1679 1036
TSI NA20774 PAQR5 progestin and adipoQ receptor family
member V
15 67439474 67483215 0.788 1048 676
CHB NA18561 CRNN cornulin 1 150648694 150651333 0.778 4845 3172
TSI NA20774 DKK4 dickkopf homolog 4 (Xenopus laevis) 8 42350775 42353720 0.760 493 362
Wu et al. BMC Bioinformatics 2012, 13:305 Page 6 of 19
http://www.biomedcentral.com/1471-2105/13/305
Table 3 Gene duplication calls in the SC dataset (Continued)
TSI NA20589 NOM1 nucleolar protein with MIF4G domain 1 7 156435193 156455158 0.740 1052 801
TSI NA20769 RNF122 ring finger protein 122 8 33525813 33535831 0.734 2574 2004
TSI NA20796 ZNF521 zinc finger protein 521 18 20896674 21184908 0.721 3536 2738
TSI NA20769 VLDLR very low density lipoprotein receptor 9 2625453 2631499 0.676 2092 1624
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sulted; (3) events that remained on the list were sent for
experimental validation. The overall FDR for the union
of calls made with and without neighboring information
can be estimated as 12.5% (3/24).
Sensitivity
We performed simulations to assess the detection effi-
ciency of our method, both for individual gene and for
pairs of neighboring genes deletions. Specifically, in each
sample we randomly selected (a) 5 out of 862 genes in
one simulation and (b) 5 pairs of neighboring genes in
another simulation. In the selected genes we down-
sampled the actual read depth seen in the experimental
data by a factor of 2 to simulate a heterozygous deletion.
The results of those simulations are presented in
Figure 3C. Of the 530 gene deletions, we detected 237
(45%). Of the 530 gene-pair deletions we detected 287
(54%). We also performed simulations on smaller sub-
sets of the original 106 samples to assess the impact of
sample size on detection sensitivity. Reduction of sample
size did not substantially degrade detection sensitivity as
long as the number of samples was >20. Therefore, our
detection efficiency is 40-45% without using neighboring
information and approximately 50-55% with the use of
neighboring information, in the SC dataset.
In addition to simulations, we compared our dataset
to a published study [17]. This study reported 12 hetero-
zygous deletion events in samples and genes (in our ter-
minology, GSS) that were part of our analyzed dataset.
We detected 6 of these 12 events, which is broadly con-
sistent with our overall sensitivity estimate.
Finally, we investigated our sensitivity to common
events (see Methods) using simulations. Figure 3D shows
detection sensitivity as a function of gene-level affinity:
for a gene affinity value of 1.8 (representing the 75th per-
centile of our data), sensitivity to common events (allele
frequency between 10% and 90%) approaches 40%. Note
that the detection efficiency starts to decrease at high al-
lele frequency (> 70%) due to a reduction of the overall
read depth because more samples have a deletion and a
corresponding depleted read depth signal. We can also
see that the median gene affinity is substantially lower
than the mean because the distribution of gene affinity
has a long tail at the high end (Figure 2D). Since sensitiv-
ity is directly related to the gene affinity, the simulated
data with the substantially higher mean gene affinity(red) has better sensitivity than with the substantially
lower median gene affinity (green).
The number of CNV events in the samples
We estimated the total number of gene deletions in the
SC dataset from the number of detected events (41), the
FDR (12.5%) and the detection efficiency (45%), as ~66,
or a nominal 0.62 deletions per sample. By projecting
the per-sample number, corresponding to 3.9% of the
exome (862 genes of 21,999), onto the whole exome, our
estimate for the average number of genic deletion events
is 16 ± 4 per sample. This estimation is representative
for the whole-exome sequencing data since the 1000
Genomes Exon Pilot Project randomly selected all the
exon targets from the CCDS collection. Our gene set is
therefore a quasi-random sampling of known human
genes, with no intentional enrichment for any given gene
family. Figure 4A and B show the distributions of exon
length in the gene list used for our analysis and the full
human exome. There is no significant difference be-
tween these two distributions: the median and the stand-
ard deviation of the exon length for our study are
125 bp and 236 bp, whereas the corresponding values
for the whole exome are 127 bp and 264 bp. The simi-
larity of these two distributions suggests that our estima-
tion of the number of events per sample is unbiased and
is representative for a whole-exome analysis.
Detection efficiency as a function of data quantity and
data quality
As discussed earlier, our algorithm’s sensitivity was ~45%
at ~87.5% accuracy. Both sensitivity and accuracy are con-
siderably lower than achievable for SNP detection in the
same datasets [16]. This poses the more general question
of how detection efficiency is influenced by sample size,
data quantity, and data quality. Our simulations show that
sensitivity only modestly depends on sample size, above
approximately 20 samples (Figure 3C).
We found that the primary factors that determine de-
tection efficiency are (i) sequence coverage, or more pre-
cisely, RD (higher RD supplies more statistical power to
detect systematic changes in coverage); (ii) the level of
over-dispersion of the RD distribution for individual
genes (the more the RD distribution departs from an
expected Poisson distribution, the less one can rely on
the statistics); and (iii) the shape of the distribution of
RD across all genes in the dataset, determined by the
Table 4 Gene deletion calls in the SC dataset
Population Sample Gene name Gene function Chr Start [bp] End [bp] Posterior
probability
RDobserved RDexpected
YRI NA18523 BCL2L15 BCL2-like 15 1 114225268 114231520 1.000 533 1158
YRI NA18523 HIPK1 homeodomain interacting protein kinase 1 1 114298778 114317657 1.000 2539 5272
TSI NA20533 GLOD4 glyoxalase domain containing 4 17 610163 632245 1.000 1322 2295
TSI NA20533 C1QBP complement component 1, q subcomponent
binding protein
17 5277059 5282317 1.000 793 1416
TSI NA20533 C17orf91 chromosome 17 open reading frame 91 17 1562414 1563890 1.000 369 574
YRI NA18523 NRAS neuroblastoma RAS viral (v-ras) oncogene
homolog
1 115052679 115060304 1.000 702 1462
YRI NA18523 TRIM33 tripartite motif-containing 33 1 114741793 114808533 1.000 2610 5225
TSI NA20533 TRPV3 transient receptor potential cation channel,
subfamily V, member 3
17 3363961 3404894 1.000 3365 5275
TSI NA20774 PTMAP1 prothymosin, alpha pseudogene 1
(gene sequence 26)
6 30725671 30728671 1.000 132 260
TSI NA20796 SNRNP27 small nuclear ribonucleoprotein 27 kDa
(U4/U6.U5)
2 69974621 69977184 0.998 105 194
TSI NA20807 HIST1H2BC histone cluster 1, H2bc 6 26231731 26232111 0.998 42 90
TSI NA20772 ULBP1 UL16 binding protein 1 6 150331436 150332954 0.997 104 205
TSI NA20807 CYP2A13 cytochrome P450, family 2, subfamily A,
polypeptide 13
19 46291375 46293686 0.996 126 204
YRI NA18508 PTMAP1 prothymosin, alpha pseudogene 1
(gene sequence 26)
6 30725671 30728671 0.992 145 230
CEU NA07000 PSG8 pregnancy specific beta-1-glycoprotein 8 19 47950287 47960273 0.990 29 70
CEU NA11893 PSG8 pregnancy specific beta-1-glycoprotein 8 19 47950287 47960273 0.985 43 86
TSI NA20771 PTMAP1 prothymosin, alpha pseudogene 1
(gene sequence 26)
6 30725671 30728671 0.980 533 862
TSI NA20773 CCK cholecystokinin 3 42274594 42280126 0.971 282 474
CEU NA07000 HMGN4 high mobility group nucleosomal binding
domain 4
6 26653414 26653686 0.966 68 132
CEU NA12749 HMGN4 high mobility group nucleosomal binding
domain 4
6 26653414 26653686 0.966 156 286
TSI NA20772 AIF1 allograft inflammatory factor 1 6 31692086 31692262 0.964 51 124
CEU NA12348 DUSP10 dual specificity phosphatase 10 1 219942377 219946216 0.962 155 242
YRI NA18508 ULBP1 UL16 binding protein 1 6 150331436 150332954 0.941 40 79
YRI NA18523 PPM1J protein phosphatase, Mg2+/Mn2+
dependent, 1 J
1 113056116 113057756 0.891 560 924
TSI NA20807 POU5F1 POU class 5 homeobox 1 6 31240884 31241803 0.891 124 193
TSI NA20772 SERPINA11 serpin peptidase inhibitor, clade A (alpha-1
antiproteinase, antitrypsin), member 11
14 93978696 93984864 0.889 786 1243
CEU NA07000 KRT18P19 keratin 18 pseudogene 19 12 51630379 51632393 0.887 85 174
CEU NA12348 ULBP1 UL16 binding protein 1 6 150331436 150332954 0.879 49 88
YRI NA18523 RHOC ras homolog gene family, member C 1 113054308 113055529 0.867 557 955
CEU NA12348 STBD1 starch binding domain 1 4 77446947 77450177 0.839 246 395
CEU NA07000 POU5F1 POU class 5 homeobox 1 6 31240884 31241803 0.823 106 169
CEU NA12749 SNRNP27 small nuclear ribonucleoprotein 27 kDa
(U4/U6.U5)
2 69974621 69977184 0.775 142 216
TSI NA20752 POU5F1 POU class 5 homeobox 1 6 31240884 31241803 0.723 76 142
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Table 4 Gene deletion calls in the SC dataset (Continued)
TSI NA20807 HIST1H2BO histone cluster 1, H2bo 6 27969220 27969600 0.723 48 88
TSI NA20589 POU5F1 POU class 5 homeobox 1 6 31240884 31241803 0.697 61 117
TSI NA20786 NPSR1 neuropeptide S receptor 1 7 34884213 34884321 0.678 51 88
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power is low in a high fraction of the genes, but this ef-
fect is not compensated by the extra coverage in other,
“over-sequenced” genes where detection efficiency is
already high, see Figure 5A below. Favorable scenarios
therefore involve distributions in which all or most
genes have sufficient RD for detection).
For each gene, we compute a quality index (QI) tak-
ing into account the variance of the expected read
depth for that gene (assuming the ideal, Poisson distri-
bution), RDexp, and a over-dispersion factor, ODF, that








QI is directly related to detection sensitivity (see
Additional file 1 for the exact formula and its deriv-
ation), as shown in Figure 5B. According to our power
calculations, for the posterior detection threshold value
we used in this study (h = 0.65), sensitivity is com-
pletely diminished for genes with QI < 5.1. QI ≥ 7.2 is
required to achieve 50% sensitivity, and QI ≥ 9.5 to
achieve 90% sensitivity. This estimated sensitivity from
QI is made only for heterozygous deletions. To achieve
the same sensitivity for detecting higher copy number
variation (CN≥3), higher QI value will be required
since the difference of prior probability between
higher copy and normal copy (CN=2) is greater than
that between heterozygous deletion and normal copy
(Table 8).
The distributions of QI values in our three datasets
are shown in Figure 5C. Overall, QI was highest in SC:
9.4 ± 8.8 (median 6.6); second highest in BI: QI = 7.6 ±
5.6 (median 6.2); and lowest in BCM: QI = 5.5 ± 2.3
(median 5.0). The corresponding distributions of detec-
tion efficiency values are shown in Figure 5A. Because
detection efficiency increases abruptly from 0 to almost
1 over a narrow range of QI values (note the mapping
between the vertical axes in Figure 5B), the distribution
of detection sensitivity (Figure 5A) is strongly bimodal,
with the vast majority of GSS having either close to zero
or close to 100% sensitivity. Even in the SC dataset with
the highest overall QI values, in less than half of the
GSS does the quantity and quality of the data support
>80% detection efficiency. There was also very substantial
variation across samples: only 15 of the 106 SC sampleshad sufficiently high coverage to support ≥ 90% overall
sensitivity, and in 22 samples overall sensitivity was below
10%.
Given that QI improves only with the square root of RD,
over-dispersion can profoundly influence detection per-
formance, as shown in Figure 5B. The ODF values we
chose for this figure correspond to the 25th, 50th and 75th
percentile, and the mean values (ODF=3, 5.5, 10, and 8, re-
spectively) in the SC dataset. Using the observed distribu-
tion of QI in the SC dataset, we predict ~46% sensitivity, in
good agreement with our estimate based on simulations.
The QI formulation permits one to estimate CNV (or
specifically in our case, heterozygous deletion) detection
power in any given exon capture dataset, based on the
read mappings. One can also use the formulation to cal-
culate the amount of base coverage required for a given
level of desired power, to guide data collection. For ex-
ample, using the distributions of QI values in the SC
dataset, one would need to collect an overall 110× cover-
age, assuming 36 bp reads, to achieve 60% detection
power, and 320× coverage to achieve 80% detection
power. However, if DNA capture methods improved to
support a median ODF=3, assuming an accordingly
scaled version of the observed distribution of QI in the
SC dataset, one would only need to collect 33× coverage
for 60% power, and 96× for 80% power. It is important to
also point out that, in the case of whole-exome data, sen-
sitivity would also improve just by virtue of the higher
density of targeted genes, if one were to integrate in one’s
pipeline neighbor-gene based detection.
Methodology comparison with CoNIFER
Krumm and his colleagues recently published a
method, CoNIFER [18], that also used read-depth sig-
nal to detect CNV in the exome capturing sequencing
data. Like our method, CoNIFER normalizes the read
depth signal in order to discover the CNV. However,
it is quite different for these two algorithms in the ap-
proach of calling samples copy number variants on the
basis that they present aberrant read depth. As we
mentioned previously, our method deploys specific
models for copy numbers 0, 1, 2, and is capable of
detecting both rare, intermediate frequency, and com-
mon CNV events. On the other hand, CoNIFER
deploys singular value decomposition (SVD) to remove
noise from the read depth data, and interprets the first
“k” singular values as noise in the data. This approach
may identify systematic variance in the data caused by
Table 5 Gene deletion calls in the BI dataset
Population Sample Gene name Gene function Chr Start [bp] End [bp] Posterior
probability
RDobserved RDexpected
CHD NA18695 TPM3 tropomyosin 3 1 152396739 152422219 1.000 166 337
JPT NA19066 TPM3 tropomyosin 3 1 152396739 152422219 1.000 169 288
CHD NA18687 RPL27A ribosomal protein L27a 11 8661325 8663929 1.000 93 182
JPT NA18983 POU5F1 POU class 5 homeobox 1 6 31240357 31241803 1.000 122 256
JPT NA19066 POU5F1 POU class 5 homeobox 1 6 31240357 31241803 1.000 166 318
JPT NA19066 RPL27A ribosomal protein L27a 11 8661325 8663929 1.000 106 203
CHD NA18687 TPM3 tropomyosin 3 1 152396739 152422219 1.000 155 258
CHD NA18687 POU5F1 POU class 5 homeobox 1 6 31240357 31241803 1.000 156 285
JPT NA19054 TPM3 tropomyosin 3 1 152396739 152422219 1.000 135 230
CHD NA18695 POU5F1 POU class 5 homeobox 1 6 31240357 31241803 1.000 194 371
JPT NA18960 SETD8 SET domain containing (lysine
methyltransferase) 8
12 122441130 122455574 1.000 221 347
CHD NA18164 RPL27A ribosomal protein L27a 11 8661325 8663929 1.000 129 223
JPT NA19054 POU5F1 POU class 5 homeobox 1 6 31240357 31241803 1.000 130 254
CHD NA18695 SETD8 SET domain containing (lysine
methyltransferase) 8
12 122441130 122455574 1.000 142 309
CHD NA18695 RPL27A ribosomal protein L27a 11 8661325 8663929 1.000 128 238
CHD NA18695 AKR1B1 aldo-keto reductase family 1,
member B1 (aldose reductase)
7 133778020 133787045 1.000 310 554
CHD NA18164 HAX1 HCLS1 associated protein X-1 1 152512874 152514801 1.000 214 339
CHD NA18687 SETD8 SET domain containing (lysine
methyltransferase) 8
12 122441130 122455574 1.000 125 237
JPT NA19054 HFE hemochromatosis 6 26201326 26202433 1.000 56 122
JPT NA18983 RPL27A ribosomal protein L27a 11 8661325 8663929 0.990 95 164
JPT NA18983 TPM3 tropomyosin 3 1 152396739 152422219 0.990 147 232
JPT NA19561 TRIM55 tripartite motif-containing 55 8 67202058 67209944 0.990 119 193
CHD NA18687 RBMS1 RNA binding motif, single stranded
interacting protein 1
2 160840394 160932124 0.990 334 575
CHB NA18757 CRIPAK cysteine-rich PAK1 inhibitor 4 1378300 1379640 0.990 327 669
JPT NA19054 PSAT1 phosphoserine aminotransferase 1 9 80109471 80113319 0.980 140 253
JPT NA19066 PSAT1 phosphoserine aminotransferase 1 9 80109471 80113319 0.980 190 317
CHD NA18164 TPM3 tropomyosin 3 1 152396739 152422219 0.980 209 317
JPT NA19568 OR8A1 olfactory receptor, family 8,
subfamily A, member 1
11 123945175 123946141 0.980 471 764
JPT NA19066 RAN RAN, member RAS oncogene family 12 129923334 129926424 0.980 229 462
CHD NA18695 KLHL12 kelch-like 12 1 201128284 201160913 0.970 767 1358
JPT NA19066 SETD8 SET domain containing (lysine
methyltransferase) 8
12 122441130 122455574 0.970 154 265
JPT NA19066 RPS15A ribosomal protein S15a 16 18706886 18707936 0.960 83 161
CHD NA18695 RPS15A ribosomal protein S15a 16 18706886 18707936 0.960 88 188
CHD NA18687 KLHL12 kelch-like 12 1 201128284 201160913 0.960 621 1041
JPT NA18983 SETD8 SET domain containing (lysine
methyltransferase) 8
12 122441130 122455574 0.960 120 213
JPT NA18983 DCTN5 dynactin 5 (p25) 16 23560365 23585966 0.960 177 298
JPT NA18983 EIF2B5 eukaryotic translation initiation factor
2B, subunit 5 epsilon, 82 kDa
3 185500333 185509372 0.940 856 1482
CHD NA18687 ARG2 arginase, type II 14 67187855 67187951 0.940 28 62
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Table 5 Gene deletion calls in the BI dataset (Continued)
CHD NA18695 PSAT1 phosphoserine aminotransferase 1 9 80109471 80113319 0.930 221 371
CHD NA18695 RBMS1 RNA binding motif, single stranded
interacting protein 1
2 160840394 160932124 0.900 442 750
JPT NA19561 OR8A1 olfactory receptor, family 8,
subfamily A, member 1
11 123945175 123946141 0.890 254 466
YRI NA19247 TIMM8B translocase of inner mitochondrial
membrane 8 homolog B (yeast)
11 111461229 111462657 0.880 40 89
CHD NA18164 POU5F1 POU class 5 homeobox 1 6 31240357 31241803 0.850 226 349
CHD NA18164 KLHL12 kelch-like 12 (Drosophila) 1 201128284 201160913 0.800 803 1276
CHD NA18164 SETD8 SET domain containing (lysine
methyltransferase) 8
12 122441130 122455574 0.790 181 291
CHD NA18687 RPS15A ribosomal protein S15a 16 18706886 18707936 0.790 81 144
JPT NA19066 EIF2B5 eukaryotic translation initiation
factor 2B, subunit 5 epsilon, 82 kDa
3 185500333 185509372 0.780 1137 1840
JPT NA19568 GABARAPL2 GABA(A) receptor-associated
protein-like 2
1 157676173 157676631 0.760 254 476
JPT NA19560 OR8A1 olfactory receptor, family 8,
subfamily A, member 1
11 123945175 123946141 0.750 614 1119
JPT NA19058 RPL27 ribosomal protein L27 17 38404294 38408463 0.730 356 518
CHD NA18699 SDPR serum deprivation response 2 192408894 192419896 0.720 524 1033
JPT NA18983 SPRR2G small proline-rich protein 2 G 1 151388989 151389210 0.670 81 147
JPT NA19066 SPRR2G small proline-rich protein 2 G 1 151388989 151389210 0.670 105 182
JPT NA19066 RBMS1 RNA binding motif, single stranded
interacting protein 1
2 160840394 160932124 0.670 404 642
JPT NA19054 EIF2B5 eukaryotic translation initiation
factor 2B, subunit 5 epsilon, 82 kDa
3 185500333 185509372 0.670 869 1470
CHD NA18695 RAN RAN, member RAS oncogene family 12 129923334 129926424 0.660 290 539
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Therefore CoNIFER has limited power for detecting
common CNV events. On the other hand, our method
is capable of detecting CNV events on the entire fre-
quency spectrum, and is therefore more generally
applicable.
Conclusions
We have developed a novel, Bayesian method to iden-
tify CNVs in exon-capture data. We applied this
method (and a simple extension using neighbor-gene
information) to the 1000 Genomes Project ExonTable 6 Gene deletion calls in the BCM dataset
Population Sample Gene name Gene function
LWK NA19355 MBD5 methyl-CpG binding domain protein
CHD NA17970 MTERFD2 MTERF domain containing 2
CHB NA18618 GABARAPL2 GABA(A) receptor-associated
protein-like 2
CHD NA18135 PSMB4 proteasome (prosome, macropain)
subunit, beta type, 4Sequencing Pilot dataset. We were able to achieve rea-
sonable sensitivity and specificity in a dataset that was
optimized for SNP discovery and, as discussed above,
is far from ideal for CNV detection. The main accom-
plishment of this work is that we provide a statistically
rigorous algorithm for CNV detection in exon capture
data, backed by experimental validations, that can be
applied to the thousands of exomes sequenced to date
in various medical projects, and to nascent and on-
going projects targeting increasingly higher numbers of
samples. Our formulation allows investigators to assess
detection power in existing datasets and to take intoChr Start [bp] End [bp] Posterior
probability
RDobserved RDexpected
5 2 148932798 148986980 0.999 618 973
2 241684086 241687982 0.996 255 393
16 74159436 74168768 0.800 58 99












Figure 3 Detected CNV events. A. Top-ranked (by posterior probability) deletion events in the SC dataset. B. Validation results for different
callsets (left – without neighboring information, right – with use of neighboring information). Green denotes events positively validated either in
our experiments or as known events [17]; red – calls validated negatively in our experiments; yellow – calls without validation status (not
submitted for validation or validation experiments without conclusive outcomes). C. Detection sensitivity as a function of number of samples.
D. Sensitivity of detecting common CNV as a function of the deleted allele frequency.
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Table 7 Validation results
Posterior ≥ 0.95 without
neighbor information
0.65 ≤ Posterior < 0.95 without
neighbor information
Posterior ≥ 0.1 with
neighbor information
Validated per previous publication 4 2 7
Validated positively de novo 11 1 7
Validated inconclusively de novo (intermediate fold change) 4 1 0
Validated negatively de novo 3 0 0
Submitted for validation but without result or no validation
attempt
0 10 3
Total calls 22 14 17
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sign for future datasets. We also uncovered >100 het-
erozygous deletion events in the 1000 Genomes
samples we examined, allowing us to estimate the
average number of heterozygous deletions per exome (as
~16 events per exome). Because we focused on algorithm
development functional assessment of these sites is beyond
the scope of this study. Nevertheless, these and other gene
deletions that will be found using our methods are very
likely to uncover events with strong functional significance.
Methods
The overall detection workflow (shown in Figure 1) con-
sists of three main steps. (1) We tabulate the observed
read depth for every GSS. (2) We determine whether the
distribution of read depth for a specific gene distribute
across samples should be modeled using simple uni-
linear fit or using a more sophisticated tri-linear fit. (3) If
the simple uni-linear fit is found suitable, we determine
an expected read depth for every GSS under a null hy-
pothesis of a normal copy number, using a simple linear
fit model. (4) Subsequently, we compare the observed
read depth for a GSS to the corresponding expectationA
Exon length (bp) 
Figure 4 Exon length distribution. A. Exon length distribution in the gen
236 bp) B. Exon length distribution of the whole exome. (median: 127 bp,
each other, suggesting our estimation of the number of events per sampleand calculate a Bayesian posterior probability for each
copy number considered (CN=0-9), threshold these, and
report events with a non-normal CN. (5) If data do not
allow for modeling using a simple uni-linear fit model,
we perform a more sophisticated tri-linear fit. The tri-
linear fit directly assigns copy number to every sample.Observed read depth
Capture sequencing reads from the 1000 Genomes Project
Exon Sequencing Pilot Project were downloaded, in
FASTQ format, from the 1000 Genomes Project DCC site:
http://1000genomes.org. The reads were mapped using the
MOSAIK read mapping program, to the NCBI build 36.3
human reference genome. The resulting read alignments
(in BAM format) were further processed to remove dupli-
cate reads, and reads with low mapping quality (<20).
Gene target regions were also downloaded from the
1000 Genomes Project site. For each GSS, we deter-
mined RD as the number of distinct reads that had their
first (5’) base uniquely mapped within an exon of that
gene. This resulted in a matrix of RD observations (illu-
strated in Figure 1C left).B
e list used for our analysis. (median: 125 bp, standard deviation:
standard deviation: 264 bp) These two distributions are very similar to
is unbiased and is representative for a whole-exome study.
C 
A B































Figure 5 Detection efficiency. A. Distributions of the detection efficiency estimated from the quality index for each gene-sample site.
B. Theoretical detection efficiency (at posterior probability cutoff h = 0.65) as a function of expected read depth, plotted for various values of the
over-dispersion factor. C. Histograms of the quality index (QI) distribution in the three datasets. Overall, QI was highest in SC: 9.4±8.8 (median 6.6);
second highest in BI: QI = 7.6 ± 5.6 (median 6.2); and lowest in BCM: QI = 5.5 ± 2.3 (median 5.0).
Table 8 Nominal prior probabilities corresponding to the
range of gene region copy numbers derived from Conrad
et al. [17]
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We discarded all duplicate reads and all reads with map-
ping quality less than 20. We also discarded all the tar-
gets with median RD less than 30. Similarly, we
discarded all the samples with median RD less than 30.
In 454-sequenced data, this led to discarding almost all
targets and samples; therefore we relaxed those criteria
to 5 and 1, respectively. Additionally, we discarded all
the genes that failed to exhibit correlation between
observed RD and MRD at r2 ≥ 0.7.
Expected read depth based on uni-linear fit and
tri-linear fit
In the first attempt, we use the simple uni-linear fit; we
calculate the expected read depth for normal copy num-
ber (CN=2) as the product of a gene-specific capture
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coverage, the median of read depths, MRDs, across all
genes for that sample:
RDgs ¼ αg :MRDs ð2Þ
The gene-specific capture affinity (αg) is determined as
the slope of a least-squares zero-intercept linear fit be-
tween the gene-specific read depth (RDgs) and the me-
dian read depth (MRDs) for all samples (illustrated in
Figure 1B). This procedure resulted in a matrix of RD
expectations (Figure 1C right).
The afore-mentioned procedure requires a single-line
linear fit between RDgs and MRDs. The quality of such a
fit is evaluated by comparing r2 against a predetermined
threshold (≥ 0.7 as described before). When this indi-
cates poor quality of the single-line linear fit, we attempt
to perform a tri-linear fit.









RDg;s  αg2 MRDs
 2
; RDg;s  0:MRDs
 2)
;
where s iterates over samples and g indicates the gene in
question. Note that the tri-linear fit directly assigns copy
number to each GSS. Please see Common CNVs for
more detail.
Copy number probabilities
We used a Bayesian scheme to calculate the probability
P(CNgs|RDgs of a given copy number at a given GSS,
based on the observed read depth. We only considered
CN=0-9 i.e. homozygous deletion (CN=0), heterozygous
deletion (CN=1), normal copy number (CN=2), and
amplifications of various magnitudes (CN>2). We
assigned prior probabilities P(CNgs) to each copy num-
ber based on CNV events reported in an earlier study
[17] (Table 8). We assumed that, for each distinct CN,
the observed RD obeys an over-dispersed Poisson distri-
bution. Its mean value for normal copy number (CN=2)
is calculated according to (Eq. 2) and for other copy
numbers it is proportionally scaled. The standard devi-
ation of the distribution includes an over-dispersion
factor (ODF) in the range of 1 to 20 to account for over-
dispersion (variance beyond the level of Poisson fluctua-
tions, see Additional file 1).
Briefly, to account for over-Poisson dispersion, we used
observed RDgs and calculated corresponding z-score under
an assumption of an ideal Poisson distribution at every
GSS. Subsequently, we calculated a sample-specific stand-
ard deviation of that z-score for every sample and anno-
tated it as sample over-dispersion factor. Similarly, wecalculated a gene-specific standard deviation of z-score for
every gene and annotated it as the gene-specific over-dis-
persion factor. If the assumption of an ideal Poisson distri-
bution were true, those sample- and gene-specific standard
deviations should equal 1. Subsequently, we calculated the
over-dispersion factor for every GSS as a product of re-
spective sample- and gene-specific ODFs. The ODF was
then normalized and assigned to 1 if less than 1.
We used the over-dispersed Poisson distributions to cal-
culate the data likelihoods P(RDgs|CN) for all considered
CN values. Finally, we used Bayes’ method to estimate the
posteriors for each considered CN. A CNV event is
reported the posterior probability of a non-normal copy
number is above a pre-defined threshold value, h.
Neighboring gene deletions
A simple extension of the algorithm used neighboring gene
deletion events as part of the detection method. For the
purpose of our algorithm, the genes were deemed “neigh-
boring” if they were located on the same chromosome, the
segment between those genes was no longer than 3 Mbp
and no gene was sequenced in between. In principle, when
a gene has a deleted neighbor, we should assume a higher
prior probability of a deletion in the gene in question. Since
the posterior probability usually scales monotonically with
the prior, for practical reasons we assumed a lower
Bayesian posterior probability threshold (h = 0.1) to pro-
duce a preliminary list of candidate events. Events on this
list for which at least one of the two immediate neighbor
genes was also on the list were retained.
Sensitivity estimation
We carried out sensitivity estimation in the SC dataset,
using simple simulations. In each simulation cycle, we
drew 5 genes randomly from every sample, and down-
scaled the observed RD for those genes by a factor of 2,
to emulate heterozygous deletions. We then applied our
standard detection procedure to this “spiked” dataset,
and tabulated the fraction of simulated events that were
detected by the algorithm.
Common CNVs
We evaluated all genes that failed to achieve r2 ≥ 0.7 using
the linear fit model from Figure 1B. The results of that
evaluation are shown in Figure 6. The last row describes
result for gene RNF150 that achieved the worst r2 of 0.48.
The histogram shown in the left columns demonstrates
distribution of observed RD to MRD (taken as from
Figure 1B), In case of a rare CNV (or lack of CNVs at all),
one would expect a unimodal distribution centered around
that gene affinity. For a common CNV, one additional peak
corresponding to CN=1 centered around half of that gene
affinity, and another peak corresponding to homozygous
deletion (CN=0) around 0, should be visible. However, the
Figure 6 Analysis of genes that failed simple linear fit. Each row describes a different gene. Left panels – distribution of the ratio of RD at the
GSS sites to the sample MRD. Right panels – distribution of the quality index for that gene. The non-multimodal distributions and the low quality-
index values of these genes suggest that there are no common CNV events on these loci.
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ther bi- or tri-modal distribution.
Additionally, the histogram of quality index calculated
for that gene is presented in the right column. The low
values of quality index further corroborate the conclusion
that the absence of a call in that locus is due to lack of highquality data rather than due to a hypothetical common
CNV event. Careful inspection of the graphs calculated for
all 69 genes the failed simple linear fit reveals lack of evi-
dence for a common CNV in any of them. Notably, in the
SC dataset only 28% of GSS in genes with r2 < 0.7 were po-
tentially detectable vs. 62% in genes with r2 ≥ 0.7.
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data, we tested the sensitivity of our algorithm using
simulated deletions. We used realistic gene affinities
(mean and three quartiles from Figure 2B) and the
empirical MRDs for 106 samples. We assumed fre-
quency of the deleted allele among 106 samples vary-
ing from 0 to 100% in 10% increments; we allowed for
random segregation, so that both homo- and heterozy-
gous deletions were introduced. Then for each sample
we calculated the expected read depth as a product of
MRD and affinity; however in the samples drawn for a
heterozygous deletion we used halves of the nominal
affinities and in the samples drawn for a homozygous
deletion, we multiplied the MRD by 0.01 to account
for reads erroneously mapped into that region. HavingA 
C 










Figure 7 Simulated Common CNVs. A. If a simple linear fit fails, the gene
error tri-linear fit between MRD and RD for that gene. B and C r2 values of
allele frequency.an expected read depth m for each sample, we drew a




pð Þ ﬃﬃﬃ2p , where ODF was assumed 8.
In Figure 7B and C we show the results of analysis
performed on simulated common CNV events. Panel B
shows r2 values obtained from the simple linear fit (as in
Figure 1B) and panel C shows the r2 values obtained
from the tri-linear fit (as in Figure 7A). The uni-linear r2
values deteriorate with the increase of the deleted allele
frequency. To the contrary, the tri-linear r2 values stay
relatively high over wide range of the allele frequency.
Finally, Figure 3D demonstrates that the sensitivity of
the algorithm to the common CNVs remains relatively
stable over wide range of the deleted allele frequency
(up to 90%).B 
affinity is estimated for each gene as the slope of the least-square-
a simple linear fit (B) and a tri-linear fit (C) as a function of the deleted
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All primers were designed using primer3 (http://fokker.
wi.mit.edu/primer3/) with default settings to obtain a
desired PCR amplicon size between 200 bp and 250 bp.
All primers were checked with BLAT (http://genome.
ucsc.edu/) to avoid known SNPs that could influence
primer hybridization. PCR products were run on an
agarose gel to make sure they gave no additional bands
besides the expected amplicon.
Primer efficiencies were determined by calculating the
standard curve of a serial dilution (4 times, 10-fold) of
pooled genomic DNA (Promega, Madison, WI). All
experiments were performed in triplicates on the Roche
LightCycler 480 platform with LightCycler 480 SYBR
Green I Master (cat# 04707516001). The volume of each
reaction was 20 μl with final primer concentrations of
400 nM. The PCR was performed according to the
following protocol: 5 min at 95°C, 2. 45 cycles of 5 s at
95°C, 10s at 60°C, 30s at 72°C. To determine the
copy number state of an event locus, we used the
Delta-Delta-Ct-Method (2-ΔΔCt) for each event locus
compared to a reference locus in the sample and a con-
trol pool of seven individuals (Promega, Madison, WI),
respectively. This reference locus was not previously
known to show any copy number variation.
Among the calls made without neighboring informa-
tion, we exhaustively validated all the calls with posterior
probability of 0.95 or more (4 coincided with known
events [17]; we experimentally validated the remaining
18 events). Additionally, we performed qPCR validations
for 4 events randomly selected from those with posterior
probability between 0.65 and 0.95 (2 coincided with
known events [17]; we experimentally validated the
remaining 2 events).
Of the calls made with the neighboring information,
we deemed 7 calls coincided with known events [17];
7 out of 10 remaining calls were submitted for qPCR
validation. For the purpose of validation, the fold change
for a given gene < 0.7 was classified as a positive valid-
ation, > 0.8 as a negative validation and in the intermedi-
ate range as inconclusive.Additional file
Additional file 1: Detail formula of over-dispersion factor (ODF) and
quality index (QI), give the exact formula and derivation of the
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